MOH 8-K: Preliminary Q2 2025 data, new 2025 EPS guidance via press release

Rhea-AI Filing Summary

Molina Healthcare, Inc. filed a Form 8-K on July 7, 2025 to furnish Item 2.02 information. The company has released a press release (Exhibit 99.1) containing preliminary, unaudited financial results for the second quarter of 2025 and an update to its full-year 2025 adjusted earnings-per-share guidance. No numerical data or qualitative detail is included in the 8-K itself; investors must review the attached press release for specifics. The disclosure is being furnished—not filed—so it is not subject to Section 18 liability or automatically incorporated into other SEC filings. Apart from customary exhibit listings (Exhibit 104 Inline XBRL cover page), the filing reports no other material events, transactions, or changes.

Insights

Financial Analyst

TL;DR: Routine 8-K furnishes press release; no numbers provided, so market impact is neutral until full details emerge.

The filing simply alerts investors that Molina has preliminary Q2 figures and revised 2025 EPS guidance, but withholds the actual metrics. Because the market cannot assess directionality—whether guidance was raised or lowered—the disclosure is informational rather than valuation-changing. Investors must wait for the press release or full earnings call to gauge performance. In short, this is a standard compliance step with minimal immediate financial impact.

Corporate Disclosure Specialist

TL;DR: 8-K is properly furnished under Item 2.02; content is limited and non-binding, posing negligible regulatory risk.

From a governance standpoint, Molina follows best practice by separating the furnished press release from filed reports, limiting potential liability. Absence of hard data keeps the document concise but also restricts investor insight. Unless the forthcoming press release contains material surprises, the current filing alone is unlikely to trigger notable market reaction.

false 0001179929 0001179929 2025-07-07 2025-07-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 7, 2025

MOLINA HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Delaware	1-31719	13-4204626
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

200 Oceangate, Suite 100,  Long Beach,  California			90802
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code: (562) 435-3666

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 Par Value	MOH	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Item 2.02.    Results of Operations and Financial Condition.

On July 7, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release announcing certain preliminary unaudited financial results for the second quarter of 2025 and updating its full year 2025 adjusted earnings per share guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report.

Note: The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.

(d)     Exhibits:

Exhibit No.	Description
99.1	Press release of Molina Healthcare, Inc., issued July 7, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		MOLINA HEALTHCARE, INC.
Date:	July 7, 2025	By:	/s/ Jeff D. Barlow
			Jeff D. Barlow
			Chief Legal Officer and Secretary

FAQ

Why did Molina Healthcare (MOH) file an 8-K on July 7, 2025?

The company furnished an 8-K to announce a press release containing preliminary Q2 2025 results and updated full-year EPS guidance.

Does the Form 8-K provide specific financial figures for Q2 2025?

No. The filing references preliminary results but does not include any numerical data; those numbers are in Exhibit 99.1.

Where can investors find Molina Healthcare’s detailed Q2 2025 results?

Details are available in the press release attached as Exhibit 99.1 to the 8-K.

Is the information in this 8-K considered "filed" with the SEC?

No. The Item 2.02 disclosure is furnished, not filed, and therefore not subject to Section 18 liability.

Were any other material events disclosed in the July 7 8-K?

No additional items, transactions, or financial statement updates were reported beyond the press release reference.